TuHURA BIOSCIENCES, INC./NV Proceeds from Issuance Initial Public Offering
TuHURA BIOSCIENCES, INC./NV (HURA) reported Proceeds from Issuance Initial Public Offering of $8.00 million for the 9-month period ending 2019-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2019-05-14
- 2019-03-31: Proceeds from Issuance Initial Public Offering 9 month $8.00M.
| Period end | Proceeds from Issuance Initial Public Offering 9 month |
|---|---|
| 2019-03-31 | $8.00M 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |